Blood Pressure Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Blood Pressure Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Summary
GlobalData's Medical Devices sector report, “Blood Pressure Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Blood Pressure Monitors pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Blood Pressure Monitors includes blood pressure transducers that convert blood pressure into electrical signals and sphygmomanometers, a device consisting of a pressure gauge and a rubber cuff that wraps around the upper arm and wrist which inflates to constrict the arteries and measure the blood pressure.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Blood Pressure Monitors under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Blood Pressure Monitors and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Blood Pressure Monitors under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
About GlobalData
Introduction
Blood Pressure Monitors Overview
Products under Development
Blood Pressure Monitors - Pipeline Products by Stage of Development
Table Figure 1: Blood Pressure Monitors - Pipeline Products by Stage of Development
Table Blood Pressure Monitors - Pipeline Products by Stage of Development
Blood Pressure Monitors - Pipeline Products by Segment
Blood Pressure Monitors - Pipeline Products under Development by Companies
Blood Pressure Monitors Companies - Pipeline Products by Stage of Development
Table Blood Pressure Monitors Companies - Pipeline Products by Stage of Development
Blood Pressure Monitors - Companies Pipeline Products by Stage of Development
Table Blood Pressure Monitors - Companies Pipeline Products by Stage of Development
Blood Pressure Monitors Companies and Product Overview
Aktiia SA Company Overview
Aktiia SA Pipeline Products & Ongoing Clinical Trials Overview
Table Aktiia SA Pipeline Products & Ongoing Clinical Trials Overview
Table Aktiia Bracelet G1 - Product Status
Table Aktiia Bracelet G1 - Product Description
Table Aktiia SA - Ongoing Clinical Trials Overview
Table Aktiia Bracelet G1 - Continual vs. Routine Home Blood Pressure Monitoring and Management in Diverse Community Practice: CHANGE-BP
Table Aktiia Bracelet G1 - Multicentric Prospective Clinical Study to Evaluate the Aktiia Optical Blood Pressure Monitoring (OBPM) Device Compared to Standard Home Blood Pressure Monitoring (HBPM) in Hypertensive Patients When Blood
Table Aktiia Bracelet G1 - Single-center Prospective Clinical Trial to Validate the Performance of the Aktiia Optical Blood Pressure Monitoring (OBPM) Device at the Wrist Against Double Auscultation
Table Aktiia Bracelet G1 - Single-center Prospective Observational Study to Validate the Performance of the Aktiia Optical Blood Pressure Monitoring (OBPM) Device at the Wrist Against Double Auscultation
Table Aktiia Bracelet G1 - Study to Evaluate the Efficacy of Aktiia Bracelet G1 in the Management of Patients with
AtCor Medical Inc Company Overview
AtCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Withings SA Pipeline Products & Ongoing Clinical Trials Overview
Table Withings SA Pipeline Products & Ongoing Clinical Trials Overview
Table BPM Core - Product Status
Table BPM Core - Product Description
Table Withings SA - Ongoing Clinical Trials Overview
Table BPM Core - Validation Study of Withings BPM Core for the Detection of Atrial Fibrillation
Table BPM Core - Wireless Automated Tracking in Cirrhosis Patients at Home (WATCH) Trial: A Randomized Single Blind
Blood Pressure Monitors- Recent Developments
Jul 25, 2023: UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2023
Jul 05, 2023: Insulet to Announce Second Quarter 2023 Financial Results on August 8, 2023
Jun 06, 2023: Emagine Solutions Technology Partners with Connected Health Pioneer Withings Health Solutions
Jun 05, 2023: OMRON Healthcare to launch operations by March 2025
May 09, 2023: GE HealthCare Names James Saccaro Vice President and Chief Financial Officer
Apr 27, 2023: OSI Systems announces fiscal 2023 Q3 financial results
Apr 25, 2023: Utah Medical Products reports financial performance for First Quarter 2023
Apr 03, 2023: InterCure Reschedules 2022 Full Year Results Conference Call
Feb 28, 2023: Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2022
Feb 24, 2023: Insulet Reports Full Year 2022 Revenue Increase of 19% and Fourth Quarter 2022 Revenue Increase of 20% Year-Over-Year
Feb 15, 2023: Bastide Sustained 14.1% growth in first-half 2022-2023
Jan 31, 2023: Fukuda Denshi Announces Summary of Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2023
Qualitative information on quarterly financial results
Jan 30, 2023: GE HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results
Jan 30, 2023: Jana Care to Enter Collaboration with Roche to Develop and Distribute Blood Testing Platform to Improve Remote Care for Patients With Chronic Kidney and Heart Disease
Jan 30, 2023: Omron Healthcare Announcement of Appointments of Directors and Executive Officers
Jan 26, 2023: OSI Systems announces fiscal 2023 Q2 results
Jan 17, 2023: GE HealthCare to Announce Fourth Quarter and Full Year 2022 Results on January 30, 2023
Jan 12, 2023: Insulet to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
Jan 12, 2023: CVRx to Report Fourth Quarter and Fiscal Year 2022 Financial and Operating Results and Host Conference Call on January 26, 2023
Jan 10, 2023: GE HealthCare Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Results; Introduces 2023 Outlook
Jan 09, 2023: CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2022 Financial Results
Jan 05, 2023: GE HealthCare appoints former Amazon exec as first chief technology officer
Dec 20, 2022: CVRx Appoints Industry Veteran Kevin Hykes to Board of Directors
Dec 08, 2022: Edwards Lifesciences Announces CEO Succession Plan
Nov 15, 2022: InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth
Nov 11, 2022: InterCure Announces Record Preliminary Third Quarter Revenue of Over CAD$39 million - 63% Growth YoY
Oct 31, 2022: Fukuda Denshi Financial Results for the Second Quarter of the Fiscal Year Ending March 2023
Oct 31, 2022: Fukuda Denshi Notice of the Revision Forecast of the Financial Results, Distribution of Surplus and Year-end Dividend Forecast, Stock Split
Oct 27, 2022: OSI Systems Reports Fiscal 2023 First Quarter Financial Results
Oct 20, 2022: Edwards Lifesciences to Host Earnings Conference Call on October 27, 2022
Oct 18, 2022: BASTIDE Announces 2021-2022 Annual Results
Oct 14, 2022: Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2022 Financial Results
Sep 29, 2022: IDT International Ltd announced interim report for 2022
Sep 22, 2022: Insulet to Announce Third Quarter 2022 Financial Results on November 3, 2022
Sep 19, 2022: Masimo names Blair Tripodi as COO for consumer division